Literature DB >> 2759174

Muscarinic receptor subtypes in human and guinea pig lung.

J C Mak1, P J Barnes.   

Abstract

Muscarinic receptor subtypes in human and guinea pig lung membranes were characterised using selective muscarinic antagonists. Competition experiments were carried out against [3H](-)-quinuclidinyl benzilate binding at 25 degrees C in Tris-HCl buffer; non-specific binding was determined in the presence of 1 microM atropine. Of all the antagonists examined, only the M1-selective antagonist pirenzepine exhibited a heterogeneous binding profile (nH less than 1.0), best described by two-binding sites of high and low affinity. Binding of [3H]pirenzepine confirmed the presence of a high proportion of high affinity (M1) receptors (60% of total) in human peripheral lung. The high potency of M3-selective antagonists 4-diphenylacetoxy-N-methyl-piperidine methiodide (4-DAMP) and hexahydrosiladifenidol suggested the presence of M3 receptors, but the low potency of AF-DX 116 and methoctramine indicated that there was no significant population of M2 receptors present. The existence of muscarinic receptor subtypes in lung may have important clinical implication but their cellular localisation remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2759174     DOI: 10.1016/0014-2999(89)90462-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Mutation screening of the muscarinic M(2) and M(3) receptor genes in normal and asthmatic subjects.

Authors:  A G Fenech; M J Ebejer; A E Felice; R Ellul-Micallef; I P Hall
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes.

Authors:  R Buchli; A Ndoye; J Arredondo; R J Webber; S A Grando
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

Review 3.  Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.

Authors:  Bart C Moulton; Allison D Fryer
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

4.  Segment-dependent expression of muscarinic acetylcholine receptors and G-protein coupling in the equine respiratory tract.

Authors:  G Abraham; C Kottke; H Ammer; S Dhein; F R Ungemach
Journal:  Vet Res Commun       Date:  2006-12-15       Impact factor: 2.459

5.  M1 and M3 muscarinic receptors in human pulmonary arteries.

Authors:  X Norel; L Walch; M Costantino; C Labat; I Gorenne; E Dulmet; F Rossi; C Brink
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

6.  Interaction of p-F-HHSiD (p-Fluoro-hexahydrosila-difenidol) at muscarinic receptors in guinea-pig trachea.

Authors:  R M Eglen; C M Cornett; R L Whiting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

7.  Isolated porcine bronchi provide a reliable model for development of bronchodilator anti-muscarinic agents for human use.

Authors:  G D'Agostino; A M Condino; L Gioglio; F Zonta; M Tonini; A Barbieri
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.